Background: Herbs have long been the basis of medical treatment but the practice of herbalism is not strictly based on evidences gathered using scientific methods. Ashwagandha (Withania somnifera L.) is a traditional medicinal herb used in the treatment of various ailments. Objective: In current study we have evaluated the acetylcholine esterase (AChE) inhibitory and antioxidant potential of Ashwagandha root extract (ARE) in in-vitro and ex-vivo models to give a scientific base to its use in herbal medicine. Methodology: Simplest extraction e.g. maceration method was performed for preparation of extracts using methanol as solvent. Both in vitro and in vivo experimental trial were executed to evaluate the efficacy of root extract. Result and Discussion: ARE substantially scavenged free radicals and effectively prevented protein degradation as well as modification as studied by SDS-PAGE and Western blotting. Pre-treatment with ARE protected rat lymphocytes against H 2 O 2 -induced oxidative damage. H 2 O 2 treatment resulted in DNA fragmentation and significantly decreased the activities of key antioxidant enzymes namely superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, glucose-6-phosphate dehydrogenase while decreased and increased the content of glutathione and malondialdehyde, respectively. ARE pre-treatment almost reversed these changes indicating its efficiency to suppress hydrogen peroxide-induced oxidative stress. Conclusion: The study provides the scientific basis of pleiotropic functions of Ashwagandha. Key words: Acetylcholine esterase, Rat lymphocytes, Antioxidants, Ashwagandha, Protein carbonylation, DNA damage. the loss of cholinergic innervation, reduction of choline acetyltransferase (ChAT) and enhanced acetylcholine esterase (AChE) activity. AChE terminates the interaction between neurotransmitter acetylcholine (ACh) and the corresponding receptor protein (acetylcholine receptor, nAChR), which is the basis of the intercellular communication in brain. Pharmacological and analytical data from human tissue and body fluids have implicated oxidation products of fatty acids in the pathogenesis of AD. 7 Antioxidants can act by scavenging the reactive products of lipid peroxidation and may be useful in prevention and treatment of AD. The modulation of AChE is presently the most accepted and recognized therapeutic marker for development of cognitive enhancers. 8 Currently used AChE inhibitors, like tacrine, produce side effects such as hepatotoxicity.
Ajay9 So, the use of natural bioactive compounds, like antioxidants, finds their possible application in the prevention and treatment of AD. Dastmalchia and his associates have summarized that interest in the discovery of natural antioxidants has risen exponentially, principally for three reasons:
303Determination of antioxidant capacity using ABTS + (2, 2'-azinobis 3-ethylbenzothiazoline-6-sulfonate) assayThe method used was the ABTS + (cation radical) decolorization assay which is based on the ability of an antioxidant ...